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1. Introduction 
The history of kidney transplantation is thought to have originated at the early beginning of 
the previous century with several attempts of Xenografting, and experimental works on 
vascular sutures (Küss & Bourget, 1992)1. But it really started more than 60 years ago with 
first attempts of deceased donor transplantation (DCD) and the first successful kidney 
transplantation of homozygote twins in Boston (Toledo-Pereyra et al, 2008)2. Belgian 
surgeons contributed to that field of medicine by performing in the early sixties the first ever 
organ procurement on a brain dead heart beating donor (DBD) (June 1963) (Squifflet, 2003)3. 
Later on, in the eighties, they published a first series of living unrelated donor (LURD) 
transplantations, as well as ABO-Incompatible living donor (ABO-Inc LD) transplantations. 
With the advent of Cyclosporine A, and later other calcineurin inhibitors such as 
Tacrolimus, with the advent of more potent immunosuppressive drugs (IS), the gap 
between the number of renal transplant candidates and the number of transplanted 
recipients was and is continuously increasing in Belgium and most countries. It opened the 
search for other sources of organs such as donors after cardiac death (DCD) defined with the 
Maastricht conference and the extended criteria donors (ECD) compared to standard criteria 
donors (SCD). In Belgium another source of DCD was identified after the promulgation in 
2002 of a law on euthanasia. The Belgian example and all its historical measures could help 
others to fight against organ shortage and its consequences, organ trafficking, 
commercialization and tourism. 
2. The prehistory of transplantation 
Already in old civilizations, the Egyptians, the Greeks, the Romans, were dreaming and 
expecting morphological changes in the structure and behavior of the human body. Old 
mythologies with their sculptures and art offer many examples such as gods, heroes, sirens, 
tritons, centaurs which are “prefiguration” of the xenotransplantation era (Küss & Bourget, 
1992)1. 
The real transplantation story started with Saints COSMAS and DAMIAN during the fourth 
century: the extraordinary influence of these physicians extended far beyond the Middle 
Ages and even into modern times (Squifflet, 2003)4. After learning the medical art, these 
legendary early Christian brothers were said to have earned so much grace through the 
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Holy Spirit that they were able to banish all diseases from man and beast. Therefore, in the 
fourth century, they transplanted a Moor’s leg to their Sacristan (Fig. 1). In Rome, the 
healing brothers were venerated, but they were also martyred under Diocletian (Fig. 2) and 
subsequently canonized. Today, they are acknowledged as the patron Saints of Surgery. 
 
 
 
Oil on wood. Wüttembergisches Landesmuseum, Stuttgart, Germany. 
Fig. 1. Transplantation of the Moor’s leg by the brothers Cosmas and Damian. 
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Sint-Jacobskerk, Brugge, Belgium. 
Fig. 2. Lancelot Blondeel’stritych on canvas. The martyrdom of the twin brothers Cosmas 
and Damian.  
At the beginning of the twentieth century (Table 1), the kidney became the pilot organ in the 
field of transplantation development with Emerich Ullmann (Vienna, Austria, 1902) who 
successfully transplanted a dog kidney into the animal neck. In parallel, the Lyon School 
with Mathieu Jaboulay described the circular suture of the arteries, a first step towards 
transplanting in 1906 a pig kidney and shortly after, a goat kidney in the inner elbow of end-
stage renal failure patients. Both kidneys rapidly thrombosed, while Mathieu Jaboulay was 
erroneously blaming his suture technique! 
An indelible mark on the pages of the transplantation history was made by one of 
Jaboulay’s pupil, Alexis Carrel who immigrated to the United States and got, later on, the 
1912 Nobel price. For vascular sutures, he moved to another technique, the so-called 
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“triangulation” while using and exchanging dog legs in order to prove its efficiency (Fig. 3). 
Even if the procedure was effective for vascular anastomosis and organ revascularization, 
Carrel mis-recognized that transplanted organ allografts were not permanently accepted. 
Indeed he did not recognize the immunological reaction and the existence of the immune 
system. Nevertheless, his surgical technique for vascular suturing is still valid and persists 
today, with several modifications introduced for microsurgery like the eccentric 
biangulation technique proposed by Cobett in the Sixties (Fig. 4) (Squifflet et al. 1993)5. 
 
Year Author Dicovery or application 
1902 
1902 
1906 
1909 
1912 
1928 
1936 
1951 
 
1952 
1954 
 
 
1962 
 
1962 
 
1962 
 
 
 
1963 
 
1966 
 
1967 
Ullmann 
Carrel 
Jaboulay 
Unger 
Carrel 
Voronoff 
Voronoy 
Küss 
 
Hamburger 
Hume 
Murray 
Merril 
Hamburger 
 
Küss 
 
to 1964 
Remtsma 
Starzl 
Hume 
Starzl 
 
Kelly Lillehei 
Barnard 
Dog kidney into the neck 
Developed vascular anastomotic techniques 
Pig and goat kidneys to the elbow 
En bloc Maccacus kidneys 
Nobel price 
Testis transplantation 
First deceased donor kidney transplantation 
Free kidneys from guillotined donors transplanted with 
surgical techniques still in use today 
First use of living related donor kidney (mother to son) 
First transplantation of identical twin kidney 
(+ first post-transplant pregnancy) 
(+ TBI: total body irradiation) 
Successful transplantations of two living related but 
non-twin kidney allografts  (TBI-Steroids) 
Successful transplantations of two non-related kidney 
Allografts (TBI-Steroids-6-Mercaptopurine) 
Xenograft period: 
5 en-bloc kidneys from chimpanzees 
6 baboon kidneys and 1 liver 
1 baboon kidney (54 Liters of urine) 
First three attempts at orthotopic liver transplantation in 
humans 25/27 successful renal transplantations with 6-MP 
First human pancreas transplantation at the University of 
Minnesota 
First transplantation of a human heart in Cape Town 
Table 1. A timeline in organ transplantation. 
In 1909, Ernst Unger used en-bloc Macaccus kidneys in humans which rapidly failed, due to 
the unknown hyperacute vascular rejection. By contrast, the success of dog autografts at the 
Mayo Clinic in Rochester helped the transplant physicians to suspect the rejection 
phenomena; it was also the open door for human kidney homografting.  
In 1928, Serge Voronoff at the Collège de France in Paris, who was well-known for his 
monkey to human testis transplantations, was ready to transplant a young girl with renal 
tuberculosis. The candidate for the organ donation was a murderer condemned to be 
beheaded, but willing to offer his organs after death. Unfortunately, the Prosecutor of the 
Republic took a wrong decision and opposed his veto. That’s why, only 5 years later, in 
1933, another Russian Surgeon, Voronoy, underwent in Kherson, the first ever renal 
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a. 
 
b. 
 
c. 
Fig. 3. Alexis Carrel (a) and his surgical technique of vascular sutures (b) exchanging dog 
legs to prove its efficiency (c). (Küss & Bourget, 1992)1. 
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a. 
 
b. 
 
c. 
a: two stitches are place on both sides at 1 hour and 11 hour, at 5 hour and 7 hour, in order 
to correctly tackle the posterior ridge of the vessels, while opening the anterior wall. 
b: the posterior running suture is placed from the inside. 
c: the anterior running suture. 
(Meurisse M., drawings). 
Fig. 4. The eccentric biangulation technique for end-to-side vascular anastomosis  
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homotransplantation in human using a kidney from a deceased–brain trauma, 60-years-old  
donor (DCD) (Blood group B). The recipient was a 26-years-old woman (Blood group O), 
who was dying from acute renal failure due to mercury intoxication. The kidney was placed 
into the groin (Fig. 5). Despite the ABO incompatibility, the urine output remained on 5 ml 
per hour until PO day 2 while the recipient died on PO day 4 with no vascular thrombosis of 
graft vessels. 
 
 
(Küss & Bourget, 1992)1. 
Fig. 5.  First renal homotransplantation by Voronoy in 1933. Implantation in the groin of the 
recipient. 
Later on, David Hume in Boston (1947) and Lawler in Chicago (1950), using again DCD 
kidney did not encounter better success; they used the Voronoy surgical technique for 
implantation. In 1951, a further and definitive step was taken in the surgical technique of 
kidney transplantation, by the French School in Paris. Dubost, Œconomos, Servelle and 
Rougeulle were using kidneys procured in guillotined murderers; Küss, Teinturier and 
Millez, used also the Matson kidney (nephrectomy of a normal kidney for ventriculo-
peritoneal shunt placement to treat hydrocephalia). All kidneys were implanted with the 
French technique: in the right iliac fossa with vascular anastomosis on the iliac vessels (Fig. 
6). That technique was used at the Necker Hospital in Paris on Christmas Eve 1952, to 
transplant Marius Renard with his mother kidney (Fig. 7). Marius had a single kidney, 
which had to be removed following a trauma (ladder fall). The mother kidney functioned 
well without any IS therapy during 3 weeks until rejection occurred, followed by recipient 
death. 
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The procedure developed by Küss and the other French surgeons is currently widely used: 
it inspired Joseph E. Murray, John Merril and their associates at the Peter Bent Brigham 
Hospital in Boston with their identical monozygotic twin transplantation, which was first 
attempted two days before Christmas 1954. The US surgeons proved without any IS agents 
that living renal transplantation could be safely performed for either the recipient who 
survived eight years, but also, for the donor (Fig. 8) who recently died at the age of 79 years 
(Murray, 2011)6. Following that attempt, other 19 twin transplantations were successfully 
performed until 1956 with a 30% recurrence rate of chronic glomerulonephritis (CGN). At 
that time, the principal ingredients of organ transplantation – immunosuppression, tissue 
matching, organ procurement and preservation – were still unknown or undeveloped. 
Therefore, the failure of all other types of grafts, usually resulting in the death of the patient, 
left little room for optimism (Groth & Longmire, 2000)7. 
 
 
 
 
 
 
a. b. 
 
 
 
 
 
(Küss & Bourget, 1992)1. 
Fig. 6. Surgical techniques for kidneys implantation. a. The groin technique (Voronoy). b. 
The French technique 
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(Küss & Bourget, 1992) 1. 
Fig. 7. The French technique used for transplanting Mr. Marius Renard at Necker Hospital 
(1952). 
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Fig. 8. Ronald Lee Herrick: first living donor for his twin brother, in December 1954 
(Murray, 2011) 6. 
3. Organ procurement and preservation 
The sudden arrival of clinical kidney transplantation during 1962-1963 was so unexpected 
that little collateral research on the preservation of organs had been done. Kidney 
transplantation was accomplished at first with total body hypothermia of living volunteer 
kidney donors using methods developed by cardiac surgeons for open heart operations. In 
the experimental laboratory, Lillehei et al. simply immersed excised intestine and pancreas 
in iced saline before its autotransplantation. Thus the principle of hypothermia was 
understood at an early time, although not efficiently applied (Squifflet et al., 2008)9. 
Today, intravascular cooling is the first step in the preservation of all whole organ grafts. 
The practice was introduced in 1963 of infusing chilled lactated Ringer’s or low-molecular-
weight dextran solutions into the renal artery of kidney grafts immediately after their 
removal. By late 1981, however, it had become obvious that pancreas, liver and thoracic 
organ transplant procedures were going to be widely used. Methods of multiple organ 
procurement were required by which the kidneys, pancreas, liver, heart and lungs or 
various combinations of these organs could be removed without jeopardizing any of the 
individual organs (Squifflet et al., 1990)10. With these methods, all organs to be transplanted 
are cooled in situ, rapidly removed in a bloodless field, and dissected on a back table (Fig. 
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9). Fluids of differing osmotic, oncotic, and electrolyte composition are infused into the 
allografts before placing them in a refrigerated container. The solution described by Collins 
et al. or modifications of it (Eurocollins®) were used for almost two decades. Renal allograft 
preservation was feasible for 1 to 2 days, long enough to allow tissue matching and sharing 
of organs over a wide geographic area (Squifflet et al., 1981)8. The introduction of the 
University of Wisconsin (UW) solution to pancreas, firstly, and then, liver transplantation in 
1988 by Belzer, Jamieson and Kalayoglu was the first major development in static 
preservation since the Collins solution. The superiority of the UW solution for preservation 
of kidneys and other organs was promptly demonstrated and confirmed in clinical trials. 
 
 
 
 
 
Fig. 9. Maneuvers for en-bloc removal of a whole pancreas and a liver from a cadaver donor 
with normal vascular anatomy. The gastroduodenal artery must be divided so that the 
common and proper hepatic arteries can remain in continuity and be retained with the liver. 
The portal vein is divided just superior to the entrance of the splenic vein. Then, the 
pancreatic portion is lengthened by an iliac vein graft. The celiac and superior mesenteric 
arteries can remain with the pancreas with a Carrel aortic patch (Squifflet et al., 1990)10. 
The ex-vivo perfusion technique also permitted good preservation of kidney or liver 
allografts. However, the complexity of the method precluded its general use. Thus, it was 
firstly abandoned in most European kidney transplant centers. A renewal of interest in the 
perfusion technique resulted from the lack of brain-dead cadaveric donors and the search 
for other sources such as the non-heart beating donors, or extended criteria donors (ECD). In 
these types of DCD kidneys, agonic ischemic damages are happening. They could be 
evaluated by a period of re-conditioning on machine perfusion prior to implantation (Moers 
et al., 2009)11. 
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4. The concept of immunosuppression and need for pharmacological agents 
in transplantation 
After Medawar’s demonstration in 1944 that rejection was an immunological event, a logical 
and inevitable question was how to protect the organ allograft by weakening the immune 
system (Table 2). 
Firstly Owen, Medawar and Billingham discovered the phenomena of neonatal tolerance, 
demonstrating that it was possible to prevent immune responses to allo-antigens. Secondly, 
works by Dausset and others (Payne, Van Rood, Bodmer, Amos, Ceppellini, Terasaki, Bach 
and Batchelor) defined what allo-antigens were, namely the major histocompatibility 
complex (MHC), which in humans is called HLA. Finally, an explosion of information about 
how the immune system works and further studies on the MHC have led to the concept of 
tissue typing, histocompatibility and cross-matching. Studies in the early 1960s defined the 
function of lymphocytes and identified separate roles for T cells (cellular immunity) and B 
cells (humoral immunity). The T cell receptor and immunoglobulins were discovered, and 
the role of HLA proteins in presenting antigens to T cells was elucidated (Turka, 2001)12 
(Halloran & Gourishankar, 2001)13. Thus, to interfere with that complex reaction, 
pharmacological agents were introduced for controlling rejection. 
 
Year Author Discovery or application 
1901 
1944 
1952 
1958 
1964 
1964  
1964 
1966 
 
 
1967 
Landsteiner
Medawar 
Dausset 
Van Rood 
Starzl 
Terasaki 
Bach 
Terasaki 
Kissmeyer- 
Nielsen 
Van Rood 
Discovery of ABO blood groups 
Rejection as an immunological event 
Discovered first HLA antigens using antiserum from 
transfused patients 
Demonstrated HLA antibodies in pregnant women  
Hyper-acute rejection of ABO-incompatible kidneys 
Description of microcytoxicity test 
Described mixed lymphocyte culture test 
 
Hyper-acute kidney rejection with antigraft 
lymphocytotoxic antibodies 
 
First international organ exchange organization 
(Eurotransplant) 
Table 2. A timeline in tissue matching and transplant immunology. 
Based upon the demonstration in 1950 that inflammatory diseases could be treated by 
adrenal steroids, it was natural to apply glucocorticoids to prevent or reserve the severe 
inflammation of graft rejection. 
By the late 1950s, the first attempts to use whole body irradiation to prolong transplant 
survival were also reported (Halloran & Gourishankar, 2001)13. But the real IS options that 
would allow for successful cadaveric transplantation emerged at the end of the 1950s. 
During that period, Elion and Hitchings developed 6-mercapto-purine (6-MP) and 
azathioprine (AZA) (Table 3). By the early 1960s, the practice of using glucocorticoids in 
conjunction with AZA had been initiated with high-dose steroid used to reverse rejection. 
The first application of antilymphocyte globulin (ALG) took place in the 1960s. Efforts at 
immune cell depletion included thoracic duct drainage, irradiation, thymectomy and 
splenectomy. 
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In 1963, during a first International Transplantation Congress in Washington, 244 renal 
allografts were reported. Among them, 28 identical twin transplants. Starlz reported also the 
first three attempts at orthotopic liver transplantation in humans as well as 25 over 27 
successful renal transplantations using 6-MP (Table 1). 
With the emerging IS therapy, it was also a period in which attempts of xenografting took 
place and quickly abandoned. 
By the late 1970s, the centers that had access to ALG were reporting improved survival rates 
in kidney transplantation. However, many patients experienced severe steroid side effects. 
Graft survival remained poor and only kidney transplants were performed in significant 
numbers with good success (Squifflet et al. 1981)8. 
The discovery of cyclosporine (CsA) and its first clinical use in 1978 changed 
transplantation. Results also improved with widespread access to effective ALG - polyclonal 
antibodies (Ab) therapy and later with the first monoclonal Ab therapy muromonab-CD3 - , 
which can reduce reliance on high-dose steroids. Many improvements in medical, surgical, 
anesthetic, and intensive care management improved clinical results. The growth in 
transplanting hearts, livers, pancreases and lungs, has created the transplantation programs 
of the present day. CsA, which blocks the transcriptional activation of IL-2 and others 
cytokines in T cells, made a significant contribution to the basic science of T cell activation.  
Tacrolimus (Tac) differed from other drugs in that much that its early development occurred 
in liver transplants, rather than in kidneys. Acting by the same mechanism as CsA, Tac 
binds to abundant intracellular protein to create a complex that inhibits the enzyme 
calcineurin. By the late 1980s, Tac was introduced for use in organ transplants. Today, it is 
the most common and largely used IS drug. 
Mycophenolate mofetil (MMF) is an agent derived from the older drug, mycophenolic acid, 
which is a potent inhibitor of de novo purine synthesis in lymphocytes and highly effective 
in combination with CsA and Tac in preventing acute rejection in humans. 
Rapamycin (or Sirolimus-Sir) had been discovered in the 1970s as an antifungal, but the 
potential of its IS properties for commercial development was not recognized until the late 
1980s. Large-scale trials have demonstrated its potential and have led to its recent approval 
for use in kidney transplantation (Table 3). 
 
Year Immunosuppressive milestones 
1950 
1959 
1968 
1978 
1981 
 
1989 
1991 
1998 
Glucocorticoid therapy in immune diseases 
6-mercaptopurine and azathioprine (AZA) 
Polyclonal antilymphocyte globulin (ALG) 
First clinical use of cyclosporine (CsA) 
Introduction of murine monoclonal anti-CD3 
to reverse rejection 
First clinical results with tacrolimus (Tac) 
First report of clinical use of mycophenolate mofetil (MMF) 
First report of clinical use of rapamycin (Sirolimus-Sir) 
Table 3. A timeline in transplant immunosuppression. 
As the third millennium begins, new humanized or chimeric protein products are becoming 
available (anti-Il2 receptors; anti-CD2; anti-CTL4 Ig; anti-CD3; anti-CD40 ligand; …). Gene 
therapy and new classes of agents such as FTY720, FK778, peptides and antisense 
oligonucleotides are currently being evaluated to determine their potential. The new priority 
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is reduction in toxicity with equivalent efficacy. However, immunosuppression would be 
tailored by better laboratory measurements of the immunological status, ischemic 
reperfusion injuries, and stability (Halloran & Gourishankar, 2001)13. 
5. The history of Deceased Donor (DCD) transplantation in Belgium 
5.1. The first cadaver – Heart Beating Donor (HBD) – kidney transplant in Belgium 
In 1962, Professor G.P.J. Alexandre obtained a fellowship for a year of surgical research to be 
spent in the laboratory of the Harvard Medical School in Boston, under the direction of 
Professor Joseph Murray, in the Department of Surgery of the Peter Bent Brigham Hospital 
directed by Professor Francis D. Moore (Squifflet, 2003)14. His initial U.S. contact in Boston 
was with Professor Roy Calne who was packing to return to England, in whom he put his 
trust to look at the surviving dogs from his experiments. The dogs were receiving the BW – 
57322 – the actual Azathioprine (AZA) – as well as other drug combinations including 
Azaserine and Actinomycin D. The later drug combination was considered good enough to 
be used in clinical practice (Fig. 10).  
 
 
Fig. 10. Proceedings of the Meeting of the American College of Surgeons, Atlantic City, 
October 16, 1962. 
Azathioprine plus Imuran is the best combination tested; a 20-day survival in 100% of animals.  
Therefore, Professor G.P.J. Alexandre returned to Belgium with both drugs in his luggage. 
Since no chronic dialysis apparatus was available in the Department of Surgery at Saint 
Pierre Hospital in Louvain where Professor G.P.J. Alexandre was completing his surgical 
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training, first candidates for renal transplantation were maintained on peritoneal dialysis, 
performed by medical students on a voluntary basis, in 24-hour rotation.  
On June 3, 1963, a patient was brought in the Emergency Department with a head injury and 
a profound coma. Despite active resuscitation and vasopressive drugs administration, the 
patient presented all the signs of what Mollaret had previously described and named “coma 
dépassé” (Mollaret & Goulon)15. Professor Jean Morelle, who was the Chief of the 
Department of Surgery and also experienced in neurosurgery, took the most important 
decision of his career: to remove a kidney from that patient while the heart was still beating. 
Moreover, and by contrast to Professor Hamburger’s donor management (Legendre & Kreis, 
2010)16, they stopped the mechanical ventilation, immediately after kidney procurement, 
waiting for the heart beat stop in the OR. No preservation fluid was used; the blood 
contained in the transplant was not even washed away; the graft functioned immediately 
without any tubular necrosis (Delayed Graft Function) and the patient’s serum creatinine 
normalized in a few days. The patient died on day 87 from sepsis; at that time of death, 
three other patients had been transplanted with that effective drug IS regimen. The third 
patient was transplanted with a living donor kidney (patient’s uncle) while the fourth, with 
a cadaver kidney: both had long term function, more than six years. In this way the kidney 
transplant program of Professor Alexandre was launched. From then on, the number of 
transplants performed annually has increased progressively and reached a mean stable 
number of 100 transplants per year in 1978 when the Department moved to Unit 22 of the 
Clinic Saint-Luc in Brussels and Professor Jean-Paul Squifflet joined the team. Professor 
Alexandre left in January 1992 while Professor Squifflet moved to Liege, CHU Sart Tilman 
in October 2005. From 1963 to 2005, during 42 years, 3.355 renal transplants have been 
performed (Table 4 and Table 5) (Squifflet J.P., 2007)17. 
 
 
Organ First transplant Number  
  Total Live donor 
Kidney (Total) 
  Kidney + liver 
  Kidney + heart 
 
Pancreas (Total) 
  Pancreas + kidney (SPK) 
  Pancreas alone (PTA) 
  Pancreas + liver 
  Pancreas after liver 
  Pancreas after failed Kd (SPK) 
  (Islets after kidney) 
June 3, 1963 
February 2, 1987 
February 23, 1986 
 
November 10, 1982 
November 10, 1982 
February 5, 1983 
September 22, 1988 
April 4, 1998 
May 11, 1999 
(October 13, 2002) 
3.355 
23 
8 
 
89 
83 (in 82 recipients) 
3 
1 
1 
1 
(2) 
501 
 
 
(Squifflet J.P., 2007)17. 
Table 4. Total number of Organ (Kidney and Pancreas) Transplantations at Saint Pierre 
Hospital in Louvain (June 3, 1963 to October 30, 1977) and Saint-Luc Hospital in Brussels 
(November 1, 1977 to September 30, 2005) by G.P.J. Alexandre (June 1963 to October 1991) 
and J.P. Squifflet (January 1978 to September 30, 2005)  
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Year Application 
June 3, 1963 
 
 
August 24, 1963 
January 20, 1965 
January 20, 1966 
June 10, 1966 
1967 
November 8, 
1967 
March 31, 1971 
September 1976 
November 1977 
January 1978 
 
June 30, 1978 
October 1982 
November 10, 
1982 
February 5, 1983 
March 1985 
March 1985 
February 23, 
1986 
June 13, 1986 
February 2, 1987 
 
July 15, 1987 
November 7, 
1989 
September 23, 
First cadaver kidney transplant 
First heart beating donor 
First use of AZA and steroids 
First living related donor renal transplant 
First haemodialysis 
First living unrelated donor renal transplant with thoracic duct 
drainage preparation 
First birth of baby from mother kidney recipient 
Creation of Eurotransplant Foundation 
Use of home-made ALG (antilymphocytic globulins) for rejection 
treatment 
First pediatric kidney transplantation 
Use of Eurocollins solution for kidney preservation 
Move from Saint Pierre Hospital in Louvain to Unit 22 Saint-Luc 
Hospital in Brussels 
Induction therapy with ALG vs ATGAM 
AZA and steroids 
First ABO-incompatible living related donor transplantation 
Introduction of cyclosporine A (CsA) 
First simultaneous kidney and pancreas transplantation in Belgium 
First pancreas transplant alone in Belgium 
Introduction of OKT3 for treating acute rejections 
Honoris Causa: Professor D.E.R. Sutherland, Professor T. Starzl, 
Professor J. Van Rood 
First simultaneous heart and kidney transplantation 
Belgian law on organ donation and transplantation (presumed 
consent) 
First simultaneous liver and kidney transplantation 
Birth of (the 3rd world) baby girl after SPK transplantation 
Introduction of bone marrow infusion after kidney transplantation 
Introduction of deoxyspergualin in kidney transplantation 
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1992 
October 12, 1993 
October 18, 1993 
February 17, 
1997 
March 2, 1997 
January 1998 
December 1998 
January 31, 2001 
June 25, 2001 
January 2002 
October 13, 2002 
 
First use of LoCD2a/BTI-322/MEDI-507 monoclonal Ab in a human 
kidney recipient 
Introduction of mycophenolate mofetil (MMF) in kidney 
transplantation 
Introduction of tacrolimus (Tac) in kidney transplantation  
First video assisted live donor nephrectomy in Belgium 
Introduction of sirolimus (Sir) in kidney transplantation 
Start of the EURO-SPK 001 trial 
Implementation of N.H.B.D. program 
Introduction of FTY 720 in kidney transplantation 
Introduction of FK 778 in kidney transplantation 
Start of the EURO-SPK 002 trial 
First human islet grafting 
 
Table 5. A timeline of the kidney and pancreas transplantation Program at Saint Pierre 
Hospital in Louvain (June 3, 1963 to October 30, 1977) and Saint-Luc Hospital in Brussels 
(November 1, 1977 to September 30, 2005) by G.P.J. Alexandre (June 1963 to October 1991) 
and J.P. Squifflet (January 1978 to September 30, 2005). 
5.2 From the brain death concept to the Belgian law on organ donation and 
transplantation 
In November 1957, Pope Pius XII released an important statement for the Catholic Church: 
he defined death as the “complete and definitive separation of the soul and the body” and 
distinguished “human life from the mere life of the organs”. He stated also that a Christian “has 
to accept the necessary treatments to preserve life and health” but that “usually this duty…requires 
only the use of ordinary means”. The Pope declared furthermore that the treatment of a patient 
in deep coma without any hope of recovery may be stopped even if this provokes cardiac 
arrest: “the interruption of resuscitation attempts is only indirectly the cause of cessation of life”. 
For deciding when exactly the soul leaves the body, if it is when the brain is destroyed or 
when the heart stops beating, the Pontiff avoided to answer the question: “the answer cannot 
inferred from any religious or moral principle and from that angle is not within the competence of the 
church”. On the contrary, he charged the clinicians “to give a clear and precise definition of death 
and the moment of death of a patient who dies in a state of unconsciousness” (Kinnaert, 2009)18. It 
was also the period during which Mollaret and Goulon proposed the term “coma dépassé” 
to describe the absence and complete destruction of cerebral functions in order to stop 
prolonging futile resuscitation (Mollaret & Goulon, 1959)15. Even if the concept was 
admitted in the transplant community, most of the surgeons were waiting for the heart beat 
stop before starting the procurement (Legendre & Kreis, 2010)16. The further step, taken by 
Professor Alexandre, in disconnecting the body in the OR after the kidney procurement was 
eventually more difficult to accept. Indeed, even T. Starzl who had performed the first 
www.intechopen.com
 Understanding the Complexities of Kidney Transplantation 
 
20
cadaver liver transplantations in 1963 did not apply it before his participation to the Ciba 
symposium in London in 1966 on Ethics in Medical Progress (Squifflet 2003)3 (Kinnaert, 
2009)18, (Ethics in Medical progress, 1966)19. The discussions he had with Professor 
Alexandre illustrate well all doubts that people had during that period. 
Alexandre:”Dr. Gierts spoke about taking organs from a dying person. I would like to make it clear 
that, in my opinion, there has never been and there never will be any question of taking organs from a 
dying person who has “non reasonable chance of getting better or resuming consciousness”. The 
question is of taking organs from a dead person, and the point is that I do not accept the cessation of 
heart beats as the indication of death. We are as much concerned with the preservation of life in a 
dying person as with the preservation of life in a fœtus: but I think irreversible damage to the central 
nervous system is an indication of physiological death that permits us to take an organ from a body 
that is already a cadaver.” 
Starzl: “Dr. Giertz has drawn a distinction between the Stockholm case and the practice in Belgium 
which seems to me to be largely quantitative. I assume that when kidneys are removed from “living 
cadavers” in Louvain, only one organ is removed, so that the patient is not thereby killed. How long 
did your patients continue to be heart-lung preparations, Dr. Alexandre? Were there any specific 
differences in the subsequent care of your cases and of the Stockholm patient? The Swedish patient 
continued to be on the respirator after the kidney was removed. If, in your practice, the respirators is 
turned off immediately after the kidney is removed this could very easily explain the different survival 
times of less than one hour in Belgium, and 48 hours in Stockholm.” 
Alexandre: “In our nine cases we switched off the respirator immediately after the kidneys were 
removed. The heart beats of all the patients ceased within two or three minutes. In my opinion it is 
irrelevant whether a heart-lung preparation goes on for two days or even for weeks: it is still a heart-
lung preparation and for us it is still a dead person.” 
Starzl: “The notion of permitting removal of our organs while we still have a circulation is an 
important one. Personally I would agree to this for myself, but I could not permit this to be done to a 
member of my family.” 
Nevertheless, that example was followed by other teams in Belgium and in most countries. 
In 1968, the French Heath Authorities published the “circulaire Jeanneney” following the Ad 
Hoc Committee of the Harvard School of Medecine (Ad Hoc Communitie, 1968)20. It opened 
the door for the first world pancreas transplantation by Kelley and Lillehei (1966), the first 
heart transplantation by Christian Barnard (1967) and the first heart transplantation in 
France by Cabrol (1968). 
In Belgium, the first lung transplantation was performed by Fritz Derom (1968), the first 
adult liver transplantation by P.J. Kestens (1969) and soon later (1970) in children by J.B. 
Otte, the first heart transplantation by G. Primo (1973) and the first pancreas transplantation 
by J.P. Squifflet (1982). 
Finally, the Belgian Transplantation community had to wait until June 1986 to get a law on 
Organ Donation and Transplantation. It includes an opting out system. Indeed, the 
transplant surgeon cannot start any organ procurement if the donor has expressed 
opposition at the National Registry, or if opposition is communicated in any way to the 
surgeon. Until 2007, it has been a soft version of the presumed consent principle because a 
first degree relative could oppose the procurement. A new step was taken in 2007 by 
suppressing this possibility and therefore turning the presumed consent principle into a 
strong version. Other important elements of the Belgian Act are that death is not defined – it 
could be brain death or cardiac death – but must be reported by 3 physicians and violent 
death must be also reported to the Public prosecutor (Squifflet A.C., 2011)21. Like other 
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European countries with presumed consent laws, Belgium was, in 2007 – and is still - , one 
of the leading countries for Multiple Organ Donors, with 27.5 cadaver donors by million 
inhabitants (pmi) and 86.5 cadaver organ transplants pmi (43.0 kidneys; 22.7 livers; 8.7 
lungs; 6.7 hearts; 5.3 pancreases/islets). As others, Belgium is also facing challenges such as 
aging donors, the use of extended criteria donors (ECD) and donors with cerebral bleeding 
as the main cause of death (Fig. 11) (Roels & Rahmel, 2011) 22. That’s why the Eurotransplant 
(ET) organization had developed its ET Senior Program (ESP) and the use of non-heart 
beating donors (NHBD), the so-called deceased after cardiac death donors (DCD) by 
opposition to the brain death donors (DBD). 
 
 
Average age 2010 effective donors: 50 yrs. 
Youngest donor: 1 year – Oldest donor: 89 years. 
46% women/54% men in 2010. 
Fig. 11. Age distribution of (effective) donors between 1990 and 2010 in Belgium. 
5.3 The first cadaver pancreas transplant in Belgium 
Professor J.P. Squifflet joined Professor G.P.J. Alexandre staff in 1978. After a research 
fellowship in transplantation at the University of Minnesota in Professor J.S. Najarian 
department, under Professor D.E.R. Sutherland’s supervision, he started a program in 
pancreatic transplantation in Brussels and performed the first Belgian simultaneous 
pancreas and kidney transplantation (SPK) in November 10, 1986 (Tables 4 and 5). The 
women recipient was also one of the first who received cyclosporine A (CsA) as the basic 
drug in the IS regimen. CsA was used at the dose of 14 mg/kg/day, considered today as a 
toxic dosage but also in combination with low doses of steroids. The second pancreas 
transplant was a segmental pancreas transplant alone (PTA). It was performed on a diabetic 
recipient with pre-end-stage renal failure, in January 1983. Unfortunately, it never 
functioned due to ischemic damage, pancreatitis and vascular thrombosis. It was promptly 
removed. By contrast, the first patient rapidly recovered from her double operation; that led 
to a series of 10 SPK procedures in 10 patients using a segment of pancreas anastomosed to a 
Roux-en-Y loop. SPK patient number 9 was transplanted in January 86 after chronic 
rejection of a first cadaver kidney graft. One year later, she delivered a baby girl: she was the 
third woman ever in the world to enjoy a successful pregnancy after pancreas 
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transplantation. Despite her nephrologist’s “disapprobation” she gave birth to a second 
baby boy in December 1990. 
On September 22, 1989, with Professor B. de Hemptinne, J.P. Squifflet performed the first 
simultaneous liver and pancreas transplant on a 34-years-old man with a type 1 diabetes 
and a cryptogenic liver cirrhosis. One year later, the patient was back on insulin therapy 
with a well functioning liver graft. He asked for a second cadaveric pancreas graft that he 
received on April 4, 1998. Unfortunately, it stopped functioning after several months. A high 
level of anti-islet antibodies was demonstrated, confirming the recurrence of the type 1 
diabetes auto-immune disease (Squifflet, 2007)17. 
The human islet program started in October 2002. The program benefited from the 
Edmonton experience but it did not succeed in reaching insulin independency with only one 
pancreatic organ for islet preparation. Therefore that activity remained marginal. 
While moving the pancreas transplantation program to the University of Liege, a new 
surgical technique was implemented (De Roover et al., 2007)23 and developed with 
mechanical sutures (De Roover et al., 2008)24. It consists in implanting the whole pancreas 
with a duodenal segment, with portal drainage (into the superior mesenteric vein) of the 
venous effluent of the pancreatic graft and exocrine diversion to the recipient duodenum. 
The latero-lateral duodeno-duodenostomy could be done using running sutures or 
mechanical staplers (Fig. 12). The advantage of that new technique is to allow pancreatic 
graft monitoring, and duodenal mucosa biopsy through serial endoscopy (Squifflet et al., 
2008)11.  
 
 
DD: latero-lateral duodeno-duodenal anastomosis. 
Portal: portal venous drainage in superior mesenteric vein (De Roover et al., 2007)23. 
Fig. 12. Whole pancreas transplantation technique with enteric drainage and portal 
drainage.  
Portal D
D
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5.4 Current challenges in Donation after Cardiac Death (DCD) 
Like in Austria and Spain which have a huge activity in DBD organ procurement, in 
Belgium it took almost 40 years to start with DCD organ procurement (Squifflet, 2006)25. The 
main reasons are multiple. 
In 1995, the first international workshop on DCD – during that period, one was speaking of 
Non-Heart-Beating Donors (NHBD) – took place in Maastricht (The Netherlands) where the 
4 categories of DCD were defined and published with 12 statements and recommendations 
(Kootstra et al., 1995)26. That was eventually approved by the European Council.  
“1. The fact that NHBD organs have to be considered for transplantation is a direct result of the 
shortage of donor organs in view of the fact that the waiting list continues to increase. The use of 
NHBD organs can be valuable way to enlarge the number of organs for transplantation. 
2. Only sparse data are available on the potential number of NHBDs and the cost of the procedure. 
More information should be collected to evaluate the efficiency of the procedure. 
3. The concept of NHBD is evolving. Therefore, it is important to show that the results are good. 
Inclusion of NHBD data in registries is necessary. 
4. For flush out and preservation methods, one should use solutions that are state of the art. Machine 
perfusion for kidneys should be considered. 
5. No NHBD program should be started without a written protocol approved by the local medical 
ethical committee. 
6. For better understanding and consistency, future reports on analysis concerning procurement and 
transplantation of NHBD organs should refer to the “Maastricht Categories”. 
 
 
 
7. Category II and III NHBD procedure should only be started 10 minutes after cessation of cardiac 
massage and artificial ventilation to ensure the “dead-donor rule”. 
8. Warm ischemia time in NHBDs should be counted from the moment of cardiac arrest until the 
start of hypothermic flush out, irrespective of the period of cardiopulmonary resuscitation. 
9. Better methods for viability testing of NHBD organs should be developed. 
10. As in HBD procedures, the diagnosis of death in a NHBD has to me made by (a) physician (s) 
independent of the procurement team. 
11. Public education and openness concerning NHBD are mandatory to keep public trust and to 
prevent backfiring on the HBD programs. 
12. Opting-out or presumed consent systems allow placement of a preservation device before contact 
with the family. In countries with opting-in legislation, legal approval for placement of such devices 
should be sought.” 
Between 1995 and 2003, the Belgian National Council of Physicians established rules for 
implementing the DCD program according to the local law. Moreover, all 7 transplant 
centers had to get a formal approval from their own local Ethical Committee. 
Finally, it was obvious that such a DCD program could not start without having access to 
machine perfusion for kidney preservation and re-conditioning. With the help of ET, a large 
international multicentric study was set up, comparing cold storage and machine perfusion 
for kidney preservation. In brief, the study demonstrated that 1 year kidney graft survival 
was 12% higher in recipient of a machine perfused graft which presented a PO delayed graft 
function (DGF) compared to recipients of a cold storage preserved graft. The length of DGF 
I  dead on arrival 
II unsuccessful resuscitation 
III awaiting cardiac arrest 
IV cardiac arrest in a brain-dead donor 
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was also significantly shorter as well as the time for GFR recovery (Moers et al., 2009)13 
(Jochmans et al., 2010)27. That study helped the Belgian Centers to implement the use of 
DCD without jeopardizing the DBD procurement rate (Fig. 13).  
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Fig. 13. Effective donor number in Belgium between 1994-2010. 
In 2009: 44% University Hospitals – 56% collaborative Hospitals. 
At the University of Liege (Le Dinh et al., 2011)28, the use of DCD had as consequence to 
double the number of donors (Fig. 14 a), to double the number of kidney transplants (Fig.  
14 b), and to 1 ½ time increase the number of liver transplants (Fig. 14 c). But it remains 
several issues to be solved. 
5.4.1 The length of the « no touch » period 
The Maastricht statement/recommendation n°7 is proposing a 10 min no-touch period after 
cessation of cardiac massage for Categories II and III. Indeed Category IV does not need a 
no-touch period as the cardiac arrest is occurring in a DBD. By contrast, 10 min might be too 
long if one considers that in categories II and III, the brain has already suffered from 
irreversible injuries. Then, the Pittsburgh School of Medicine protocol proposes a 2 min 
waiting time (Institute of Medicine, 1997)29. Today, there is a national consensus between all 
Belgian Centers to declare that a no-touch period of 5 minutes could be enough, but it has 
not been formally set up yet.  
5.4.2 The comfort therapy 
Even if intensivists are respecting and protecting all dying patients, they agree to avoid 
futile sufferances while accompanying the patient in his agonic phase. By contrast, others 
(Feng S., 2010)30 think that obstacle against administration of drugs could be the logistics of 
individual and institutional informed consent for the donor and the potential organ 
recipients. For the above reason, most intensivists are administering what they call a 
comfort therapy, while withdrawing the unnecessary support. Therefore improved 
education of health care professionals and providers on the early recognition and special 
needs of this DCD population i.e. comfort therapy and implementation of clinical protocol 
should improve the yield of transplantable organs. Aggressive donor protocols will include 
early aggressive clinical management of DCD donors including comfort therapy. It requires 
the help of dedicated health care specialists. 
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Fig. 14a 
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Fig. 14b 
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Fig. 14c 
Fig. 14. Proportion of DCD/DBD donors (a), kidney (b) and liver (c) transplantations 
between 1995 and 2009 at the University of Liege (Hieu et al, 2011)28. 
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5.4.3 The DCD management: Monitoring awaiting cardiac arrest and drug 
administration 
Unfortunately, today DCD management varies from hospitals to organ procurement 
organizations, from physicians, nurses, administration and institutional review boards 
along with donor families (Feng S., 2010)30. It is worth remembering that donors are not 
concentrated in a few hospitals but rather scattered throughout the community. Therefore, a 
primary barrier to donor management is the need to reach consensus across a broad 
coalition of parties that stem from distinctive spheres.  
A second obstacle for making uniform DCD management and drug intervention is the 
logistics of individual and institutional informed consent for the donor and the potential 
organ recipients. The definition of human subjects does not encompass DCD after they are 
legally dead but there is a grey shade period between the decision of stopping futile 
reanimation with family consent and the recognition of cardiac death, during which DCD 
management with drug administration takes an important place. That should require the 
intervention of independent well trained teams working according to ethical consensus and 
guidelines. The decision of stopping futile reanimation should be taken by 3 physicians, 
knowing that a small proportion of patients in a vegetative or minimally conscious state 
have brain activation reflecting some awareness and cognition. Careful clinical examination 
will result in reclassification of the state of consciousness in some of these patients, in order 
to avoid subsequent unuseless prolonged warm ischemic time which contra-indicaties DCD 
organ procurement (Monti et al., 2010)31. That should be done according to family wishes. 
Thereafter, and only thereafter, the DCD organ procurement procedure should be proposed, 
discussed with the next-of-skin, and informed consent should be obtained. After 
administration of the comfort therapy (5.4.2.), mechanical ventilation support is withdrawn 
with or without the endotracheal tube. If extubation is taking place, the tube must be 
replaced during organ procurement for lungs recovery. Arterial blood pressure is measured 
via a femoral – better than radial – artery catheter, along with peripheral oxygen saturation 
(Spo2) and Fio2. Systolic blood pressure should decrease lower than 30 mmHg, the heart rate 
down to zero, along without any Spo2 waveform. The patient is pronounced dead by the 
physical examination 5 minutes after the absence of any systemic anterograde blood flow 
(through the femoral artery catheter) (DuBose and Salim, 2008)32. Drug administration, like 
heparin, is following Ethics guidelines for research with the recently dead (Pentz et al., 
2005)33. 
5.4.4 Brain Death monitoring while waiting cardiac arrest 
Current DCD organ procurement procedures make DCD heart graft not suitable for 
transplantation. Usually, cardiac valves are prepared for homografting. Research is also 
ongoing and consists in putting the heart graft on normothermic machine perfusion system 
in order to re-condition the graft during several hours before implantation. Nevertheless, if 
one could monitor for BD during the DCD procurement procedure, it will allow heart and 
other organs recovery before waiting for cardiac arrest and the end of the no-touch period, 
while decreasing the warm ischemic time. 
The first attempt to monitor a DCD category III, controlled case for BD was done by J.M. 
Guerit in 2005, using the somatosensory evoked potentials (Guerit et al., 1999)34. By the left 
median nerve monitoring, he observed the disappearance of the P14 wave, while the 
dropping blood pressure reached the 51/27 mmHg value (Fig. 15).  
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NHBD cat III case
Left median nerve monitoring
Time 01:09 p.m. BP 51/27 mm Hg 
No P14 wave
 
Fig. 15. The brain death (BD) monitoring during the DCD organ procurement procedure 
(Guerit, 2006)36. Disappearance of the P14 wave of somatosensory (left median nerve) 
evoked potentials with dropping blood pressure.  
Another tool, proposed by Auyong et al. is following the bisprectal index (BIS). They 
presented a case series of increased BIS values during DCD procedure. If these increased BIS 
values could be a consequence of the catecholamic storm, which could represent a new 
monitoring tool of BD with the disappearance of BIS. But, limitations of BIS and 
electroencephelography are well known, the last one being the worst traditionally 
recommended tool for BD confirmation (Guerit, 2004)35 (Guerit, 2006)36. Nevertheless, if 
these observed changes were not due to artefact, dosing of hypnotic or anaesthetic drugs 
might be warranted (Auyong et al., 2010)37. Moreover, it will open doors for recovering 
more DCD organs including hearts for transplantation. But it will need further 
manipulations to counteract the agonic phase lesions and ischemic injuries, like the 
intermediate use of machine perfusion for re-conditioning all grafts. 
6. The living donor (LD) renal transplantation 
The first attempt to LD renal transplantation took place as early as 1962 when no IS drugs 
were available in Belgium. Indeed, it was a first unrelated LD (LURD) kidney graft which 
rapidly failed (Kinnaert, 2009)18. Soon later, Professor Alexandre was more fortunate in 
performing living donor renal transplantation (LRD) using the Boston IS regimen. In 1968, 
he added to the IS armentorium the use of homemade antilymphocyte serum. Horses of the 
Belgian Police Corps and Army, disqualified for duty, were brought to the Hospital 
laboratories and injected with thoracic duct lymphocytes. These lymphocytes were being 
collected from recipients of LD kidneys who, in that period of time, were prepared, during 5 
days before the operation, with drainage of the thoracic duct (TDD). After immunization, 
the horses were bled for extracting the antilymphocyte globulins, for injection into the 
recipients. Later on, Behringwerke Pharmaceuticals (Germany) took over this preparation 
known as the Behring horse antihuman ALG (Pressimmum ®) which was still in use until 
the eighties and from which thousands of patients had benefited. Initially ALG was used to 
treat steroid resistant acute cellular rejections. Since 1976, it had been used as induction 
therapy along with Aza and steroids. Moreover in LD recipients, a TDD was added to that 
protocol along with a per-tranplant splenectomy. In October 1982, CsA was combined to 
that basic IS regimen: that quadruple drug therapy was the reference treatment for more 
than 10 years. It allowed using low doses of each IS drug, avoiding toxic side-effects, while 
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hoping an IS synergistic effect (Squifflet et al., 1982)38. During the CsA period, for LD 
transplantation, TDD and splenectomy were abandoned.  
6.1 The pediatric renal transplantation 
The real advantages of using LD kidneys over DBD during the pre CsA era became obvious 
with the first results obtained in the pediatric population comparing parental to cadaver 
donation (Fig. 16) (Squifflet et al., 1981)39. 
 
 
Fig. 16. Renal Transplantation in Children.  
Graft survival in 32 parental and 35 cadaver graft in pediatric recipients during the pre CsA 
era (1971-1981). Numbers beside survival curses refer to the number of graft at risk. 
Difference between the two curses is significant (P < 0.02) and reaches > 30% at 5 years 
(Squifflet et al., 1981)39. 
 
Fig. 17. Renal Transplantation. Kidney survival in 56 parental and 26 cadaver graft in 
pediatric recipients during the CsA era (1983-1994). Difference between the two curves 
reaches > 30% at 10 years (Malaise et al., 1995)40. 
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Twenty years later during the CsA era, that was confirmed in the same pediatric population. 
Surprisingly, the difference in functional survival rates between the 2 subgroups remained 
similar but it was more than 30% at 10 years, instead of 5 years (Fig. 17). Even if one year 
results improved with the CsA use, the slope of the curves were parallel (Malaise et al., 
1995)40. 
The children experience underlined the advantages of LD over the DBD renal 
transplantation. It allows donor selection according to strict medical, serological and 
anatomical criteria. It insures the quality of the grafts and can help for selection of potential 
live donors according to the HLA matching (twins, HLA identical siblings, parental…). 
Moreover the procedure can be programmed without any waiting on dialyse i.e. pre 
emptive procedure. The recipient can also be prepared by donor specific transfusions 
and/or pre-transplant IS therapy and/or bone marrow infusion or others. Working in 2 
separate operating rooms, it can reduce ischemic injuries with a hemodynamically stable 
donor. Finally it increases donor self-esteem and the cadaver donor pool.  
6.2 The Living Unrelated  Renal Transplantation (LURD) 
In looking at our LD activity (Table.5 and Fig. 18 a and b) the proportion of LD/DBD was 
globally 18%, but decreased slowly during the last decade, despite LD promotion. 
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Fig. 18. LD/CDV renal transplantation (Prof. G.P.J. Alexandre and J.P. Squifflet activity) 
from 06/1963 to 12/2004. 
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The explanation of the phenomena is to be found in looking at mean ages of recipients and 
donors: for the recipients, it increased from 30 to 50 years and 20 to 40 years for DBD and 
LD respectively (Fig. 19 a); for the donors, it increased only for DBD from 25 to 40 years but 
remains stable for LD, around 40 years of age (Fig. 19 b). One can conclude that our selection 
criteria for the LD did not change over time; for the aging population of recipients, most of 
their LRD candidates are not fulfilling the donation criteria. Thus, LURD could be another 
source for renal transplantation; that source in our program, increased slowly over time (Fig. 
20). 
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Fig. 19. evolution of mean ages of recipients (a) and donors (b) from 1980 to 2004 according 
to donor sources: DBD red curves and LD yellow curves. 
The LURD program started in 1966. During the pre CsA era, 17 were performed under AZA 
and Steroids as the basic therapy, plus ALG for induction, TDD and splenectomy (Squifflet 
et al., 1990)41. With the advent of CsA, 41 new LURD were performed between 1983 and 
1996, and were compared to paired 82 DBD renal transplantations (Fig. 21) (Malaise et al., 
1997)42. 
It is interesting to note that the donor-to-recipient relationship was 22 wife-to-husband, 9 
husband-to-wife, 1 aunt-in-law, 1 brother-in-law, 1 wife’s niece, 1 mother-in-law, 4 close 
friends and 2 family’s friends. In that series, LURD renal transplantation offered similar 
results (Fig. 21 a and b) than DBD, despite poorer HLA-A, B and Dr matching and older 
donor age. The waiting time on dialysis was shorter; early better graft function was 
encountered in relation to the reduced total ischemia time and better preparation 
(conditioning) of both donors and recipients. Moreover the video-assisted donor 
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nephrectomy technique introduced for the late cases did not increase the incentive to LD 
(Berney et al. 2000)43. 
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Fig. 20. Proportion LRD/LURD (Squifflet et al., 1990)41 ; (Malaise et al., 1997)42. 
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b. 
Fig. 21. Comparison of LURD and DBD kidney transplantations under CsA therapy: similar 
actuarial patient (a.) and renal graft (b.) survival rates (Malaise et al., 1997)42. 
 
6.3 The ABO-incompatible (ABO-Inc) living donor renal transplantation 
Early in 1981, an ABO-Inc cadaver kidney transplant was accidentally performed (blood 
group A1 into an O recipient). Despite a rejection crisis on the third week with a sharp 
increase of the anti-A iso-agglutinins, the renal function completely recovered. The patient 
survived more than 25 years post-transplantation with a functioning kidney graft. 
Using a similar approach to that used for achieving ABO-Inc bone marrow transplantation, a 
series of 39 ABO-Inc live donor kidney transplants (31 related and 8 unrelated donors) was 
successfully performed (Table 6). The recipients received donor-specific platelet transfusions, 3 
to 5 plasmapheresis to get rid of the anti-donor iso-agglutinins and underwent splenectomy at 
the time of transplantation (Alexandre et al., 1985)44. Twenty years graft survival is as high as 
76% in the youngest recipients (< 15 years) (Squifflet et al., 2004)45. It compares favorably with 
ABO-compatible LD renal transplantation (Fig. 22 a. and b.).  
 
 
Table 6. Outcome of 39 ABO-Inc related and unrelated living donor (LD) kidney 
transplantations. 
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a. 
 
b. 
a. Kidney graft survival in recipients < 15 years (n=9) and > 15 years (n=22) of ABO-Inc 
LRD. 
b. Kidney graft survival in recipients < 15 years (n=9) of ABO-Inc LRD compared to a group 
of recipients < 15 years (n=58) of ABO-Comp LRD (Malaise et al., 1995)40. 
Fig. 22. ABO-Inc LRD: 20 years later (Squifflet et al. 2004)45. 
More surprising is the fact that some patients may carry very high levels of iso-agglutinins 
with the disappearance of all ABO blood group antigens on the endothelial cells of the 
transplanted kidney. Later on, Fritz Bach (Bach et al., 1997)46 proposed the word 
“accommodation” to name this phenomena; probably there exists a critical period, before 
the third postoperative week, during which the ABO-Inc transplant is at risk for acute 
humoral vascular rejection. That is followed by a period of adaptation.  
Today, more than 20 years later, each part of the original protocol has been further assessed 
or modified by different groups. Indeed, plasmapheresis was replaced by immuno 
adsorption columns. For deleting the last circulating iso-agglutinins, high doses of 
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intravenous immunoglobulins are communally used. Pre-transplant IS includes Rituximab 
®, as well as at the time of transplantation, in order to avoid the splenectomy. In general, the 
PO IS therapy combines Tacrolimus and Mycophenolate Mofetil with r-ATG induction 
(Squifflet et al., 2004)45. 
Today, excellent results can be achieved: it is the demonstration that crossing the ABO 
barrier in LD kidneys transplantation is feasible. The same heavy protocol pertains and can 
also be applied for hyper immunized recipients with positive crossmatch against potential 
donors. Others, as well as the Belgian transplant community,  
have proposed LD exchange programs (LDEP). Currently, in the Netherlands, that LDEP is 
very successful in helping numerous pairs of D and R from blood group O, while solving 
impossibilities (Fig. 23) by incorporating donations from good samaritans.  
 
D
R
D
R
̇ Incompatible bloodtype
̇ Positive cross-match
 
 
Fig. 23. Solving impossibilities with LDEP. 
Based on that human experience and using the same preparation, a dozen pig-to-baboon 
renal xenografts were achieved in the mid-eighties. Three animal recipients survived 10, 22 
and 23 days respectively. The baboon who lived for 10 days died of a pulmonary infection: 
the renal function was normal at the time of death and histology of the xenograft was 
remarkably normal. Two baboons, who lived for over three weeks, presented an acute 
rejection crisis at the end of the first week, vascular in nature for the first animal and cellular 
in the second one. This demonstrated that, together with an appropriate preparation of the 
donor animal and the recipient, xenotransplantation could be feasible using new potent 
immunosuppressive drugs.  
7. Present and future perspectives 
On May 28, 2002 Belgium adopted the Belgian act on Euthanasia after several months of 
intensive discussions (Squifflet A.C., 2011)21. Euthanasia is described as ‘an act on purpose, 
performed by a third person, in order to end the life of a person who has requested for this act’. The 
rules are the following:  
The patient must be an adult or an emancipated minor, capable and conscious at the time of 
his / her request. The request is made voluntarily, is well thought out and reiterated, and is 
not the result of outside pressure.  
The patient is in a hopeless medical condition and complains of constant and unbearable 
physical or mental pain which cannot be relieved.  
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If the person is not in the terminal phase of his illness, the 2 doctors must consult with a 
third doctor, either a psychiatrist or a specialist in the disease concerned.  
At least one month must pass between the written request and carrying out the act. 
Every euthanasia must be reported to a federal commission that regulate the practice and 
bring prosecutions when necessary.  
Current statistics demonstrate more than 2 acts per day in Belgium and 7 per day in the 
Netherlands (Fig.24). 
 
 
 Total        Decl. in Dutch       Decl. in French 
Fig. 24. Annual numbers of legal euthanasia acts in Belgium. 
In January 2005, a first woman who was following the procedure of mercy killing asked for 
organ donation after death (Ysebaert et al., 2009)47, (Detry et al., 2008)48. She was followed by 
7 others persons so far. Data concerning the 4 patients are summarised in table 7 and 8 
(Ysebaert et al., 2009)47. 
The organ procurement procedure which was adopted after euthanasia was as follow:  
- Extensive written informed consent of donor - if possible (see patient 2) - and relatives. 
- Strict separation between euthanasia request, euthanasia procedure and organ 
procurement. 
- Euthanasia performed by 2 physicians + neurologist. 
- Euthanasia in wheelchair (patients 1, 3, 4) or bed (patient 2), in a special room in the OR, 
in presence of the family. 
- Organ retrieval after clinical diagnosis of cardiac death by 3 physicians. 
- Procedures performed by senior staff members and nursing staff on a voluntary basis. 
- Euthanasia procedure induced by overdose barbiturates, muscle relaxation and 
analgesia. 
- Heparine given after euthanasia kit. 
- The surgical procedure:  
- 3 times femoral vessels cannulation  using the DBTL catheter (double balloons triple 
lumen) followed  by a quick laparotomy for topical cooling (patients 1, 3 and 4).  
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Location Age Condition 
Date of 
Euthanasia 
1. UZA 
44 
CVA since 6 years, fixed hemliplegia, cortical 
blindness, special disorientation and dyspraxia. 
01/2005 
2. U of Lg 
43 
CVA since 4 years, locked-in syndrome, no motor 
recovery, central hyperthermia episodes, 
communication only by the eyes. 
06/2006 
3. UZA 
47 
Multiple sclerosis since 10 years, wheel chair 
dependent, depending on third parties for personal 
care, no quality of life, large decubitus wounds. 
07/2007 
4. UZA 
50 
Multiple sclerosis since 16 years, wheel chair 
dependent, depending on third parties for personal 
care, no quality of life. 
10/2007 
UZA: Universiteit Ziekenhuis Antwerpen 
U of Lg: University of Liege, CHU Sart Tilman 
Table 7. demographic data of the first 4 Belgian donors who requested organ donation after 
euthanasia (Ysebaert et al., 2009)47. 
- 1 time a quick laparotomy for insertion of the aortic and inferior vena cava canule, 
and topical cooling (patient 2). 
- Organ allocation via Eurotransplant (for DCD kidneys, allocation is allowed 4 hrs 
before). 
- Transplant centers informed about the nature of the case and the elements of organ 
procurement. 
Based on that protocol, the first 4 patients donated 8 kidneys, 4 livers, 3 pancreases for islet 
preparation and 4 lungs. All those organs were successfully transplanted without delayed 
graft function and need for P.O. dialysis for the kidneys (table 8). 
 
Patient First warm ischemic times Outcome 
 
Start – 
Asystoly 
Asystoly – 
Incision 
Incision – 
flush 
Total Kidneys Liver Islets Lungs 
1 12’ 9’ 5’ 26’ 2 Yes Yes No 
2 9’ 3’ 5’ 17’ 2 Yes No No 
3 21’ 8’ 5’ 34’ 2 Yes Yes 2 
4 6’ 5’ 3’ 14’ 2 yes yes 2 
Table 8. First warm ischemic times and outcomes of the organs procured in the first 4 
Belgian donors who requested organ donation after euthanasia (Ysebaert et al., 2009)47. 
The potential number of patients asking for euthanasia who fulfilled criteria for organ 
donation will remain limited and was estimated to be between 5 and 10% (table 9). 
That first series demonstrates that organ donation after euthanasia is feasible. It allows 
respecting strong patient’s wish to donate that cannot be denied. The proposed procedure 
clearly separates euthanasia request, euthanasia procedure and organ procurement. It 
ensures high quality of DCD organs which might enter in a so-called Fifth Category of 
Maastricht, of controlled NHBD.  
A step further was undertaken by a Pediatric Heart Transplantation team from Denver, 
Colorado (Boucek et al., 2008)49 who procured 3 pediatric DCD hearts after a no-touch 
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 2003 2004 2005 2006 2007 2008 2009 
Euthanasia 235 349 393 429 495 704 822 
Neuromuscular disorders 22 27 16 33 48 51 58 
% 9,5 7,7 4,1 7,6 9,6 7,2 7,0 
Table 9. Potential number of patients fulfilling organ donation criteria among Belgian 
patients requesting euthanasia (Squifflet A.C., 2011)21. 
period of 3, 1.25 and 1.25 minutes. All 3 hearts were successfully transplanted into 3 
children. Therefore, the Denver procedure extends the boundaries of organ donation after 
circulatory death, and perhaps, will require ethical discussions and revisions of the 
definition of death. Currently the definition of brain death requires the complete absence of 
all functions of the entire brain (higher-brain definition). The cardiac definition of death 
requires the irreversible cessation of cardiac function (impossible to reverse). Based on the 
Denver procedure, the last definition is not valid anymore. It means also, that in DCD organ 
procurement, with a neuromonitoring of brain death, and adequate analgesic drug 
management, cessation of cardiac beats could not be waited for, even without any no-touch 
period. It will also allow heart procurement, reconditioning on artificial device before 
implantation.  
That will necessitate the revision of the dead donor rule and the endorsement of the DCD 
procedure by separate well trained teams.  
The Belgian initiatives in the field of cadaver organ procurement have paid off in terms of 
number of organs available for allocation. But it remains, like in other countries, that the 
number of suboptimal organs is increasing for recipients of increasing age and associated 
morbidities. That will impair the short – and long-term graft and patient outcome. 
If there is an urgent need for those centers performing living donor transplantation to turn 
toward cadaveric organ transplantation, there is also an urgent need for those centers which 
have DCD programs to turn toward living donor transplantation which offers better results. 
Current situation prevails: many persons are willing to offer their organs after death in 
hoping to help their neighbours. Many patients with end-stage renal disease are turning to 
live donor kidney transplantation to improve survival and quality of life. Many healthy 
adults are eager and willing to accept the risk of donor nephrectomy to help their loved 
ones. Therefore, the responsibility is within the medical community to quantify the risks as 
best as possible and make the information available to those considering donation. That 
should be considered and will help for avoiding organ trafficking, tourism and 
commercialisation in the field of renal transplantation. 
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